Vanguard Group Inc Century Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,377,494 shares of IPSC stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,377,494
Previous 2,381,707 0.18%
Holding current value
$1.28 Million
Previous $2.41 Million 52.56%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.48 - $1.11 $2,022 - $4,676
-4,213 Reduced 0.18%
2,377,494 $1.14 Million
Q4 2024

Feb 11, 2025
SELL
$1.0 - $1.72 $93,508 - $160,833
-93,508 Reduced 3.78%
2,381,707 $2.41 Million
Q3 2024

Nov 13, 2024
BUY
$1.44 - $3.29 $1.07 Million - $2.44 Million
743,082 Added 42.9%
2,475,215 $4.23 Million
Q2 2024

Aug 13, 2024
BUY
$2.46 - $4.05 $1.46 Million - $2.4 Million
593,480 Added 52.12%
1,732,133 $4.42 Million
Q1 2024

May 10, 2024
BUY
$3.19 - $5.32 $44,660 - $74,480
14,000 Added 1.24%
1,138,653 $4.76 Million
Q4 2023

Feb 14, 2024
BUY
$1.28 - $3.32 $7,018 - $18,203
5,483 Added 0.49%
1,124,653 $3.73 Million
Q3 2023

Nov 14, 2023
SELL
$2.0 - $3.23 $57,110 - $92,232
-28,555 Reduced 2.49%
1,119,170 $2.24 Million
Q2 2023

Aug 14, 2023
BUY
$2.91 - $3.53 $106,668 - $129,395
36,656 Added 3.3%
1,147,725 $3.63 Million
Q1 2023

May 15, 2023
BUY
$3.4 - $5.11 $114,229 - $171,680
33,597 Added 3.12%
1,111,069 $3.86 Million
Q4 2022

Feb 10, 2023
BUY
$4.84 - $11.58 $42,514 - $101,718
8,784 Added 0.82%
1,077,472 $5.53 Million
Q3 2022

Nov 14, 2022
BUY
$8.57 - $13.1 $1.39 Million - $2.12 Million
161,713 Added 17.83%
1,068,688 $10.6 Million
Q2 2022

Aug 12, 2022
BUY
$7.96 - $12.43 $694,215 - $1.08 Million
87,213 Added 10.64%
906,975 $7.62 Million
Q1 2022

May 13, 2022
BUY
$11.62 - $15.92 $3.16 Million - $4.33 Million
271,760 Added 49.59%
819,762 $10.3 Million
Q4 2021

Feb 14, 2022
BUY
$13.93 - $23.62 $1.58 Million - $2.68 Million
113,392 Added 26.09%
548,002 $8.69 Million
Q3 2021

Nov 12, 2021
BUY
$20.8 - $31.93 $8.42 Million - $12.9 Million
404,610 Added 1348.7%
434,610 $10.9 Million
Q2 2021

Aug 13, 2021
BUY
$22.45 - $29.34 $673,500 - $880,200
30,000 New
30,000 $880,000

Others Institutions Holding IPSC

# of Institutions
69
Shares Held
26.9M
Call Options Held
12.1K
Put Options Held
0
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $31.8M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email